Yiting Lu

721 total citations · 1 hit paper
42 papers, 407 citations indexed

About

Yiting Lu is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yiting Lu has authored 42 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Surgery and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yiting Lu's work include Ion Transport and Channel Regulation (6 papers), Hormonal Regulation and Hypertension (5 papers) and Cardiomyopathy and Myosin Studies (4 papers). Yiting Lu is often cited by papers focused on Ion Transport and Channel Regulation (6 papers), Hormonal Regulation and Hypertension (5 papers) and Cardiomyopathy and Myosin Studies (4 papers). Yiting Lu collaborates with scholars based in China, Taiwan and United States. Yiting Lu's co-authors include Lin Zhao, Zenglei Zhang, Xu Meng, Xianliang Zhou, Xianliang Zhou, Wenzheng Liu, Fu‐Chen Huang, Peng Fan, Kun‐Qi Yang and Xian‐Liang Zhou and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Biological Macromolecules and Heart.

In The Last Decade

Yiting Lu

36 papers receiving 404 citations

Hit Papers

Insulin resistance assessed by estimated glucose disposal... 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiting Lu China 10 133 90 84 81 54 42 407
Joaquim Barreto Brazil 11 139 1.0× 99 1.1× 69 0.8× 75 0.9× 87 1.6× 35 406
Zhifang Wang China 15 222 1.7× 39 0.4× 146 1.7× 80 1.0× 25 0.5× 36 604
Chih‐Wen Wang Taiwan 12 86 0.6× 39 0.4× 192 2.3× 35 0.4× 20 0.4× 52 493
Mahmoodreza Khoonsari Iran 10 150 1.1× 67 0.7× 211 2.5× 23 0.3× 88 1.6× 35 452
Ramazan Kocabaş Türkiye 10 45 0.3× 38 0.4× 58 0.7× 52 0.6× 55 1.0× 23 342
Yiping Xu China 12 46 0.3× 146 1.6× 59 0.7× 37 0.5× 27 0.5× 43 453
Xiaoli Wu China 10 247 1.9× 63 0.7× 85 1.0× 43 0.5× 120 2.2× 23 440
Di Shen China 11 64 0.5× 46 0.5× 86 1.0× 57 0.7× 18 0.3× 30 345
Sanjay Sarin India 15 38 0.3× 125 1.4× 134 1.6× 196 2.4× 195 3.6× 39 662
Ajith Dissanayake New Zealand 10 76 0.6× 71 0.8× 29 0.3× 116 1.4× 82 1.5× 17 530

Countries citing papers authored by Yiting Lu

Since Specialization
Citations

This map shows the geographic impact of Yiting Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiting Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiting Lu more than expected).

Fields of papers citing papers by Yiting Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiting Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiting Lu. The network helps show where Yiting Lu may publish in the future.

Co-authorship network of co-authors of Yiting Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yiting Lu. A scholar is included among the top collaborators of Yiting Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiting Lu. Yiting Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Lixin, Jiahui Xu, Yiting Lu, et al.. (2025). Discovery of 2-tetrahydroisoquinoline substituted quinazoline derivatives as lysine methyltransferase G9a inhibitors with in vivo antitumor efficacy. European Journal of Medicinal Chemistry. 300. 118113–118113.
2.
Luo, Yuanyuan, Yarong Hao, Chunyan Sun, et al.. (2025). Gut-derived indole propionic acid alleviates liver fibrosis by targeting profibrogenic macrophages via the gut‒liver axis. Cellular and Molecular Immunology. 22(11). 1414–1426. 1 indexed citations
3.
Lu, Yiting, Di Zhang, Xinchang Liu, et al.. (2023). Identification of a novel frameshift mutation in the SCNN1B causing Liddle syndrome. Science Bulletin. 68(4). 383–387. 3 indexed citations
4.
Lu, Yiting, et al.. (2023). Clinical characteristics and management of coexistent cardiomyopathy in patients with bicuspid aortic valve. Journal of Geriatric Cardiology. 20(3). 205–213. 2 indexed citations
5.
Lu, Yiting, et al.. (2023). Predicting stroke and myocardial infarction risk in Takayasu arteritis with automated machine learning models. iScience. 26(12). 108421–108421. 5 indexed citations
6.
Zhang, Zenglei, Lin Zhao, Yiting Lu, Xu Meng, & Xianliang Zhou. (2023). Association between Chinese visceral adiposity index and risk of stroke incidence in middle-aged and elderly Chinese population: evidence from a large national cohort study. Journal of Translational Medicine. 21(1). 518–518. 34 indexed citations
7.
Lu, Yiting, et al.. (2023). Glucose-regulated protein 94 facilitates the proliferation of the Bombyx mori nucleopolyhedrovirus via inhibiting apoptosis. International Journal of Biological Macromolecules. 253(Pt 5). 127158–127158. 7 indexed citations
8.
Pongkiatkul, Prapat, et al.. (2023). Strategy Design of PM2.5 Controlling for Northern Thailand. Aerosol and Air Quality Research. 23(6). 220432–220432. 3 indexed citations
9.
Zhang, Zenglei, Lin Zhao, Yiting Lu, Xu Meng, & Xianliang Zhou. (2023). Relationship of triglyceride-glucose index with cardiometabolic multi-morbidity in China: evidence from a national survey. Diabetology & Metabolic Syndrome. 15(1). 226–226. 13 indexed citations
10.
Lu, Yiting, et al.. (2023). Characterization of a silkworm UFM1 homolog in regulating Bombyx mori unfolded protein response and nucleopolyhedrovirus replication. Biochemical and Biophysical Research Communications. 675. 162–169. 2 indexed citations
11.
Lu, Yiting, Philip J. Harding, Kanthashree Mysore Sathyendra, et al.. (2023). Model-Internal Slot-triggered Biasing for Domain Expansion in Neural Transducer ASR Models. 1324–1328. 1 indexed citations
12.
Lu, Yiting, Peng Fan, Håkon Håkonarson, et al.. (2023). Monogenic hypertension-a type of “curable” hypertension. Science Bulletin. 68(7). 657–660.
14.
Lu, Yiting, Zeming Zhou, Di Zhang, et al.. (2022). A Novel Frame-Shift Mutation in SCNN1B Identified in a Chinese Family Characterized by Early-Onset Hypertension. Frontiers in Cardiovascular Medicine. 9. 896564–896564. 1 indexed citations
15.
Lu, Yiting, et al.. (2021). Identification of NF1 Frameshift Variants in Two Chinese Families With Neurofibromatosis Type 1 and Early-Onset Hypertension. Frontiers in Pediatrics. 9. 785982–785982. 3 indexed citations
16.
Luo, Yuanyuan, Yiting Lu, Binbin Li, et al.. (2021). Alterations of gut microbiome and metabolite profiles in choledocholithiasis concurrent with cholangitis. Hepatology International. 16(2). 447–462. 6 indexed citations
17.
Lu, Yiting, et al.. (2020). A Case Report of Acupuncture at Neiguan Point (P6) for Paroxysmal Supraventricular Tachycardia. Complementary Medicine Research. 27(5). 364–368. 2 indexed citations
18.
Lu, Yiting, et al.. (2019). Site-directed mutation to improve the enzymatic activity of 5-carboxy-2-pentenoyl-CoA reductase for enhancing adipic acid biosynthesis. Enzyme and Microbial Technology. 125. 6–12. 10 indexed citations
19.
Xu, Shaoyan, et al.. (2016). Laparoscopic resection of benign schwannoma in the hepatoduodenal ligament: A case report and review of the literature. Oncology Letters. 11(5). 3349–3353. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026